Roundtable Discussion: Adopting AI Effectively in Analytical Development to Reduce Unnecessary Cost & Complexity

9:30 am - Thursday 3rd December 2026

  • Exploring where AI genuinely reduces workload versus adding validation burden, cost, or review time
  • Using historical data responsibly to support credible AI-assisted decisions, including where the GxP boundary sits and what documentation is required either side of it
  • Comparing how large and small organizations are adopting AI differently, and what each can learn from the other’s constraints

Speakers:

Analytical Assay Development Manager & Head of Quality Control
Expression Therapeutics LLC